BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioCapital

  India Globalization Capital Provides Update on Hyalolex for Alzheimer’s Commercialization Strategy

  Here’s an update on corporate initiatives to launch its lead product for Alzheimer’s.

  December 14, 2017

   · 

  2 min read
• Business

  MassBio Announces New VP of Programs & Global Affairs

  In this role, Elizabeth will oversee all planning and execution of the organization’s annual Signature Events, along with running MassBio’s economic development and global affairs department.

  December 14, 2017

   · 

  2 min read
• Business

  Cinfa Biotech Begins U.S. Partnering and Prepares U.S. Development for B12019, a Proposed Biosimilar to Neulasta (Pegfilgrastim)

  Cinfa Biotech S.L. today announced the start of US partnering and the preparation of US development for its drug candidate B12019, a biosimilar of Neulasta to treat chemotherapy-induced neutropenia.

  December 14, 2017

   · 

  2 min read
• Business

  Counsyl Appoints Pamela Sedmak to Board of Directors

  Counsyl today announced the appointment of Pamela Sedmak, former president and chief executive officer of Aetna Medicaid/Dual Eligibles and current senior advisor at McKinsey & Company, to the company’s board of directors.

  December 14, 2017

   · 

  3 min read
• Molecular Characterization of Circulating Tumor Cells isolated with GILUPI Technology from Prostate Cancer Patients

  GILUPI GmbH announces the recent publication of a clinical study demonstrating multiplex gene expression profiling of cTCs isolated in vivofrom high-risk prostate cancer patients by the use of GILUPI CellCollector.

  December 14, 2017

   · 

  1 min read
• Drug Development

  IU Researchers Identify Way to Block Malaria-Causing Parasites’ Ability to Shield Themselves Against Popular Drug Treatment

  Indiana University School of Medicine researchers have identified a way to block the ability of parasites that cause malaria to shield themselves against drug treatments in infected mice-a finding that could lead to the development of new approaches to combat this deadly disease in humans.

  December 14, 2017

   · 

  2 min read